Differential regulation of MMPs by E2F1, Sp1 and NF-kappa B controls the small cell lung cancer invasive phenotype

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Li, Zunling ^a,b   Guo, Yanxia ^a   Jiang, Hanming ^a   Zhang, Tingguo ^a   Jin, Changzhu ^b   Young, Charles Y F ^c   Yuan, Huiqing ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

^c Mayo Clinic   (China)

Author keywords

E2F1; Matrix metalloproteinases; p65; SCLC; Sp1

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; SMALL INTERFERING RNA; STROMELYSIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN RECEPTOR; PROTEIN KINASE; SP1 KINASE;

ADULT; AGED; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL MIGRATION; CHINESE; CHROMATIN IMMUNOPRECIPITATION; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHENOTYPE; PROGNOSIS; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; VERY ELDERLY; WESTERN BLOTTING; BIOSYNTHESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SMALL CELL LUNG CANCER; TUMOR CELL LINE;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN KINASES; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; TRANSCRIPTION FACTOR RELA;

EID: 84899646385     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-276     Document Type: Article

References (44)

1. Lu HY, Wang XJ, Mao WM. Targeted therapies in small cell lung cancer. Oncol Lett 2013, 5(1):3-11. 3525471, 23255884.
2. Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol 2012, 181(6):1895-1899. 10.1016/j.ajpath.2012.08.044, 3506216, 23063657.
3. Shah SA, Spinale FG, Ikonomidis JS, Stroud RE, Chang EI, Reed CE. Differential matrix metalloproteinase levels in adenocarcinoma and squamous cell carcinoma of the lung. J Thorac Cardiovasc Surg 2010, 139(4):984-990. discussion 990, 10.1016/j.jtcvs.2009.12.016, 2844342, 20304142.
4. Yamamura T, Nakanishi K, Hiroi S, Kumaki F, Sato H, Aida S, Kawai T. Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas. Lung Cancer 2002, 35(3):249-255. 10.1016/S0169-5002(01)00431-7, 11844598.
5. Leinonen T, Pirinen R, Bohm J, Johansson R, Ropponen K, Kosma VM. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis. Lung Cancer 2006, 51(3):313-321. 10.1016/j.lungcan.2005.11.002, 16423426.
6. Stenvold H, Donnem T, Andersen S, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM. Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome. Lung Cancer 2012, 75(2):235-241. 10.1016/j.lungcan.2011.06.010, 21764478.
7. Rintoul RC, Sethi T. The role of extracellular matrix in small-cell lung cancer. Lancet Oncol 2001, 2(7):437-442. 10.1016/S1470-2045(00)00421-6, 11905738.
8. Michael M, Babic B, Khokha R, Tsao M, Ho J, Pintilie M, Leco K, Chamberlain D, Shepherd FA. Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J Clin Oncol 1999, 17(6):1802-1808.
9. Johnson JL, Pillai S, Pernazza D, Sebti SM, Lawrence NJ, Chellappan SP. Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease. Cancer Res 2012, 72(2):516-526. 10.1158/0008-5472.CAN-11-2647, 3261351, 22086850.
10. Gottschall PE, Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 1996, 3(2-3):69-75.
11. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet 2010, 11(3):204-220. 10.1038/nrg2719, 3034103, 20142834.
12. Labrie M, St-Pierre Y. Epigenetic regulation of mmp-9 gene expression. Cell Mol Life Sci 2013, 70(17):3109-3124. 10.1007/s00018-012-1214-z, 23184252.
13. Vincenti MP, Brinckerhoff CE. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?. J Cell Physiol 2007, 213(2):355-364. 10.1002/jcp.21208, 17654499.
14. Chetty C, Rao JS, Lakka SS. Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma. Pharmacogenomics 2011, 12(4):535-546. 10.2217/pgs.10.207, 21521025.
15. Ji W, Zhang W, Xiao W. E2F-1 directly regulates thrombospondin 1 expression. PLoS One 2010, 5(10):e13442. 10.1371/journal.pone.0013442, 2955548, 20976175.
16. Minato Y, Tashiro E, Kanai M, Nihei Y, Kodama Y, Imoto M. Transcriptional regulation of a new variant of human platelet-derived growth factor receptor alpha transcript by E2F-1. Gene 2007, 403(1-2):89-97.
17. Pillai S, Kovacs M, Chellappan S. Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res 2010, 70(12):4931-4940. 10.1158/0008-5472.CAN-10-0501, 2891185, 20516113.
18. Banerjee D, Gorlick R, Liefshitz A, Danenberg K, Danenberg PC, Danenberg PV, Klimstra D, Jhanwar S, Cordon-Cardo C, Fong Y, Kemeny N, Bertino JR. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res 2000, 60(9):2365-2367.
19. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh G, Golemis EA. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol Cell Biol 1996, 16(7):3327-3337. 231327, 8668148.
20. Li J, Hu SX, Perng GS, Zhou Y, Xu K, Zhang C, Seigne J, Benedict WF, Xu HJ. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene 1996, 13(11):2379-2386.
21. Eymin B, Gazzeri S, Brambilla C, Brambilla E. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene 2001, 20(14):1678-1687. 10.1038/sj.onc.1204242, 11313916.
22. Hu Z, Gu Y, Han B, Zhang J, Li Z, Tian K, Young CY, Yuan H. Knockdown of AGR2 induces cellular senescence in prostate cancer cells. Carcinogenesis 2012, 33(6):1178-1186. 10.1093/carcin/bgs141, 22467239.
23. Shao S, Li Z, Gao W, Yu G, Liu D, Pan F. ADAM-12 as a Diagnostic Marker for the Proliferation, Migration and Invasion in Patients with Small Cell Lung Cancer. PLoS One 2014, 9(1):e85936. 10.1371/journal.pone.0085936, 3897605, 24465799.
24. Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y, Yuan H. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 2011, 307(2):141-148. 10.1016/j.canlet.2011.03.026, 21511395.
25. Liu YQ, Hu XY, Lu T, Cheng YN, Young CY, Yuan HQ, Lou HX. Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-kappaB signaling in prostate cancer cells in vitro and in vivo. PLoS One 2012, 7(5):e38000. 10.1371/journal.pone.0038000, 3362538, 22666431.
26. Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol 2004, 203(3):744-753. 10.1002/path.1582, 15221933.
27. Hung JJ, Hsueh CT, Chen KH, Hsu WH, Wu YC. Clinical significance of E2F1 protein expression in non-small cell lung cancer. Exp Hematol Oncol 2012, 1(1):18. 10.1186/2162-3619-1-18, 3514097, 23210897.
28. Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res 2007, 13(23):6938-6946. 10.1158/1078-0432.CCR-07-1539, 18056168.
29. Kuhn H, Liebers U, Gessner C, Schumacher A, Witt C, Schauer J, Kovesdi I, Wolff G. Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis. Eur Respir J 2002, 20(3):703-709. 10.1183/09031936.02.00294502, 12358350.
30. Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C, Papavassiliou AG. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002, 198(2):142-156. 10.1002/path.1121, 12237873.
31. DeMuth JP, Jackson CM, Weaver DA, Crawford EL, Durzinsky DS, Durham SJ, Zaher A, Phillips ER, Khuder SA, Willey JC. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells. Am J Respir Cell Mol Biol 1998, 19(1):18-24. 10.1165/ajrcmb.19.1.3077, 9651176.
32. Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res 2009, 15(5):1741-1746. 10.1158/1078-0432.CCR-08-1372, 19240177.
33. Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res 2001, 29(21):4361-4372. 10.1093/nar/29.21.4361, 60184, 11691923.
34. Murthy S, Ryan AJ, Carter AB. SP-1 regulation of MMP-9 expression requires Ser586 in the PEST domain. Biochem J 2012, 445(2):229-236. 3663053, 22519702.
35. Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J, Li M. Sp1 is upregulated in human glioma, promotes MMP-2-mediated cell invasion and predicts poor clinical outcome. Int J Cancer 2012, 130(3):593-601. 10.1002/ijc.26049, 21469139.
36. Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ, Hong WK, Aggarwal BB, Wistuba II. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 2006, 107(11):2637-2646. 10.1002/cncr.22315, 17078054.
37. Zhang SY, Liu SC, Johnson DG, Klein-Szanto AJ. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 2000, 60(21):5972-5976.
38. Lin SY, Black AR, Kostic D, Pajovic S, Hoover CN, Azizkhan JC. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol 1996, 16(4):1668-1675. 231153, 8657142.
39. Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W. E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem 2004, 279(7):5110-5117.
40. Rotheneder H, Geymayer S, Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J Mol Biol 1999, 293(5):1005-1015. 10.1006/jmbi.1999.3213, 10547281.
41. Wong CF, Barnes LM, Dahler AL, Smith L, Popa C, Serewko-Auret MM, Saunders NA. E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line. Oncogene 2005, 24(21):3525-3534. 10.1038/sj.onc.1208372, 15735752.
42. Chen M, Capps C, Willerson JT, Zoldhelyi P. E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation 2002, 106(21):2707-2713. 10.1161/01.CIR.0000038706.30661.86, 12438297.
43. Shaw J, Yurkova N, Zhang T, Gang H, Aguilar F, Weidman D, Scramstad C, Weisman H, Kirshenbaum LA. Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Proc Natl Acad Sci U S A 2008, 105(52):20734-20739. 10.1073/pnas.0807735105, 2603431, 19088195.
44. Gang H, Dhingra R, Wang Y, Mughal W, Gordon JW, Kirshenbaum LA. Epigenetic regulation of E2F-1-dependent Bnip3 transcription and cell death by nuclear factor-kappaB and histone deacetylase-1. Pediatr Cardiol 2011, 32(3):263-266. 10.1007/s00246-011-9893-z, 21293853.